Ibogamine-18-carboxylicacid,14-[(2R,3aR)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-2-yl]-13-hydroxy-,methyl ester (9CI) (76202-19-2)

Identification
Name:	Ibogamine-18-carboxylicacid,14-[(2R,3aR)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-2-yl]-13-hydroxy-,methyl ester (9CI)
Synonyms:	Ibogamine-18-carboxylicacid,14-(2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-2-yl)-13-hydroxy-,methyl ester, [14(2R,3aR)]-; 1H-Indolo[3,2,1-de][1,5]naphthyridine,ibogamine-18-carboxylic acid deriv.;6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole, ibogamine-18-carboxylicacid deriv.; Isobonafousine
CAS:	76202-19-2
Molecular Formula:	C35H40 N4 O3
Molecular Structure:
Properties
Safety Data

Other Product

Ibogamine-18-methanol,14-[(2R,3aR)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-2-yl]-13-hydroxy-(9CI)
Ibogamine-18-methanol,14-[(3aR,6R)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-yl]-13-hydroxy-(9CI)
Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-19-(2-oxopropyl)-, methyl ester (9CI)
methyl (2alpha)-14-[(3aR,6R)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-yl]-13-hydroxyibogamine-18-carboxylate
Ibogamine-18-carboxylicacid, 14-[(3a,20b)-19,20-dihydro-17-methoxy-17-oxovobasan-3-yl]-13-methoxy-19-(2-oxopropyl)-,methyl ester, (19R)- (9CI)
Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-, methyl ester
Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-19-oxo-, methyl ester (9CI)
3-methyl-6-prop-2-en-1-yl-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-ol
ethyl 2-((3aR,4S)-4-ethyl-4-(2-methoxy-2-oxoethyl)-6-oxo-3a,4,5,6-tetrahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-3(2H)-yl)acetate
Ibogamine-18-carboxylicacid, 13-methoxy-12-[(3a)-17-methoxy-17-oxovobasan-3-yl]-, methyl ester
Ibogamine-18-carboxylicacid, 13-hydroxy-, methyl ester (9CI)
3-prop-2-en-1-yl-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one hydrochloride
3-[(2E)-but-2-en-1-yl]-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one hydrochloride
3-prop-2-yn-1-yl-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one hydrochloride
Dynorphin A (swine),13-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysinamide]-14-de-L-tryptophan-15-de-L-asparticacid-16-de-L-asparagine-17-de-L-glutamine-, [3aS-(3aa,4b,6aa)]- (9CI)
10H-3,8a-Methano-1H-azepino[1',2':1,2]pyrrolo[2,3-b]indole-14-carboxylicacid,4-ethylidene-2,3,4,5,7,8-hexahydro-11-[(2R,3S,5S,7aR,12aR,12bS,13S)-1,3,4,6,7,12,12a,12b-octahydro-3-[(1R)-1-hydroxyethyl]-10-methoxy-12-methyl-14-oxo-2H-3,2,7a-(epoxyethanylylidene)indolo[2,3-a]quinolizin-9-yl]-10-oxo-,methyl ester, (3R,4E,6S,8aR,13aR,14S)- (9CI)
methyl 13-hydroxy-14-{[3-(methoxycarbonyl)-2,3,6,7-tetradehydroaspidospermidin-17-yl]oxy}ibogamine-18-carboxylate
Furo[2,3-g]indolo[2,3-a]quinolizine-1-carboxylicacid, 3a-ethyl-2,3a,4,6,7,12-hexahydro-2-oxo-, methyl ester, (3aR)-
13H-3,8a-Methano-1H-azepino[1',2':1,2]pyrrolo[2,3-b]indole-14-carboxylicacid,4-ethylidene-2,3,4,5,7,8-hexahydro-10-methoxy-13-methyl-11-[(3S,3aR,5aS,8aR,13aS)-1,3,3a,4,5,8,8a,13a-octahydro-3-[(1R)-1-hydroxyethyl]-11-methoxy-1-oxo-7H-3,6-methanofuro[3',4':5,6]pyrido[1,2-a]pyrrolo[2,3-b]indol-10-yl]-,methyl ester, (3R,4E,8aR,13aR,14R)- (9CI)
Spiro[2H-2,7a-methanoindolo[2,3-a]quinolizine-3(4H),2'-oxirane]-13-carboxylicacid,9-[(3R,4E,6S,8aR,13aR,14S)-4-ethylidene-2,3,4,5,7,8-hexahydro-14-(methoxycarbonyl)-10-oxo-10H-3,8a-methano-1H-azepino[1',2':1,2]pyrrolo[2,3-b]indol-11-yl]-1,6,7,12,12a,12b-hexahydro-10-methoxy-3',12-dimethyl-,methyl ester, (2R,2'R,3'R,5S,7aR,12aR,12bS,13S)- (9CI)